Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | PYGB | P11216 | 1/20 | 0.44 |
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28909059 | 1.00 | L3MBTL1 (0.46) | L3MBTL1LGALS8GAATYRMAPT | |
| SCHEMBL27775938 | 1.00 | L3MBTL1 (0.46) | L3MBTL1LGALS8GAATYRMAPT | |
| SCHEMBL16934775 | 1.00 | L3MBTL1 (0.46) | L3MBTL1LGALS8GAATYRMAPT | |
| SCHEMBL6410535 | 0.89 | LGALS8 (0.56) | L3MBTL1LGALS8GAATYRMAPT | |
| SCHEMBL1097983 | 0.89 | LGALS8 (0.56) | L3MBTL1LGALS8GAATYRMAPT | |
| SCHEMBL229813 | 0.89 | LGALS8 (0.56) | L3MBTL1LGALS8GAATYRMAPT | |
| SCHEMBL17938837 | 0.89 | L3MBTL1 (0.46) | L3MBTL1LGALS8GAATYRMAPT | |
| SCHEMBL12613799 | 0.86 | LGALS8 (0.50) | L3MBTL1LGALS8GAATYRMAPT | |
| SCHEMBL9507333 | 0.86 | PYGB (0.53) | L3MBTL1LGALS8GAAMAPTPYGB | |
| SCHEMBL1098459 | 0.86 | LGALS8 (0.50) | L3MBTL1LGALS8GAATYRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590117-B2 | Hexose derivatives, preparation and uses thereof | FACULDADE DE CIENCIAS DA UNIVERSIDADE DE LISBOA (PT) | 2026-03-31 | — | — | US | disclosed |
| US-20230357301-A1 | HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF | FACULDADE DE CIENCIAS DA UNIVERSIDADE DE LISBOA (PT) | 2023-11-09 | — | — | US | disclosed |
| US-11708387-B2 | Hexose derivatives, preparation and uses thereof | FACULDADE DE CIÊNCIAS DA UNIVERSIDADE DE LISBOA (PT) | 2023-07-25 | — | — | US | disclosed |
| CN-115448964-A | Hexose derivatives and their formulations and use | 里斯本大学科学与技术学院 | 2022-12-09 | — | — | CN | disclosed |
| US-20180170955-A1 | HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF | UNIVERSIDADE NOVA DE LISBOA (PT) | 2018-06-21 | — | — | US | disclosed |
| EP-3116886-A1 | HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF | Faculdade De Ciências da Universidade de Lisboa (PT) | 2017-01-18 | — | — | EP | disclosed |
| WO-2015137838-A1 | HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF | EXTREMOCHEM, LDA. (PT) | 2015-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180170955-A1 | HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF | HK1, SLC5A1, HK2 | L3MBTL1 3975/4885LGALS8 1014/4885GAA 1568/4885 |
| US-20230357301-A1 | HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF | HK1, SLC5A1, HK2 | L3MBTL1 3975/4885LGALS8 1014/4885GAA 1568/4885 |
| US-12590117-B2 | Hexose derivatives, preparation and uses thereof | SLC5A1, HK1, SLC5A2 | L3MBTL1 4199/4885LGALS8 345/4885GAA 2176/4885 |
| US-11708387-B2 | Hexose derivatives, preparation and uses thereof | HK1, SLC5A1, HK2 | L3MBTL1 3975/4885LGALS8 1014/4885GAA 1568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.